Pancreatic Cancer Research

ResearcherArmy Medical UniversityActive in the last 2 years

Xiaowu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8221-7064; OpenAlex author ID A5100683747. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
2
Collaborators
37
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 3 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplantation tumor model induced by PANC-1/ADR … Co-author DOI 10.7150/ntno.109280↗
  2. CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy. Co-author DOI 10.1186/s40164-024-00533-3↗
  3. NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocar… Co-author DOI 10.1021/acsptsci.2c00159↗
  4. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Last author DOI 10.1038/s41419-022-04677-0↗
  5. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma. Last author DOI 10.3389/fonc.2022.827259↗
  6. Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-021-01902-0↗
  7. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-019-1436-0↗
  8. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Last author DOI 10.1016/j.canlet.2018.04.035↗
  9. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41388-018-0237-9↗
  10. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor met… Last author DOI 10.1186/s13046-018-0822-3↗
  11. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. Last author DOI 10.18632/oncotarget.20692↗
  12. Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1. Co-author DOI 10.3892/ijo.2017.4018↗
  13. The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer. Last author DOI 10.1186/s13000-015-0445-3↗
  14. miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death. Co-author DOI 10.1186/1476-4598-12-105↗
  15. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Last author DOI 10.1093/carcin/bgr088↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhonghu Li · 8 shared papers, 2015–2021 · strength 0.66
  2. Hui Liu · 2 shared papers, 2024–2025 · strength 0.56
  3. Qiqian Liu · 2 shared papers, 2022–2025 · strength 0.48
  4. Jolanda Spadavecchia · 2 shared papers, 2022–2025 · strength 0.48
  5. Peng Jiang · 7 shared papers, 2011–2018 · strength 0.47
  6. Kun Cai · 2 shared papers, 2022–2024 · strength 0.44
  7. Shiyu Chen · 1 shared paper, 2024 · strength 0.26
  8. Zhiwei He · 1 shared paper, 2024 · strength 0.26
  9. Xiushen Li · 1 shared paper, 2024 · strength 0.26
  10. Shuguang Wang · 3 shared papers, 2011–2021 · strength 0.24
  11. Jie Li · 3 shared papers, 2018 · strength 0.22
  12. Weidong Jin · 2 shared papers, 2019–2021 · strength 0.21
  13. Zhirui Zeng · 1 shared paper, 2022 · strength 0.19
  14. Zhiwei He · 1 shared paper, 2022 · strength 0.19
  15. Wenpeng Cao · 1 shared paper, 2022 · strength 0.19
  16. Shan Lei · 1 shared paper, 2022 · strength 0.19
  17. Xun Gong · 1 shared paper, 2022 · strength 0.17
  18. Xin Zhao · 2 shared papers, 2018 · strength 0.15
  19. Yingqiang Xu · 2 shared papers, 2015–2017 · strength 0.13
  20. Guo Wu · 2 shared papers, 2015–2017 · strength 0.13
  21. Yan Xiang Chen · 1 shared paper, 2021 · strength 0.12
  22. Jin Yang · 1 shared paper, 2017 · strength 0.09
  23. Yan Chen · 1 shared paper, 2019 · strength 0.09
  24. Xiangde Liu · 1 shared paper, 2018 · strength 0.08
  25. Xi Zhang · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.